Abstract #1932
RRx-001 Oxidation of Redox Sensitive Protein Thiols in Tumors Measured by Gd-LC7-SH Enhanced MRI In Preclinical Tumor Models
Natarajan Raghunand 1 , Jan Scicinski 2 , Bryan Oronsky 2 , Bhumasamudram Jagadish 3 , Eugene A Mash 3 , and Ronald L Korn 4
1
Cancer Imaging & Metabolism, Moffitt Cancer
Center, Tampa, Florida, United States,
2
RadioRx
Pharmaceuticals, Mountain View, California, United
States,
3
Dept.
of Chemistry & Biochemistry, The University of Arizona,
Tucson, Arizona, United States,
4
Imaging
Endpoints LLC, Scottsdale, Arizona, United States
We have investigated the kinetics of T1-shortening
produced in 3 pre-clinical tumor xenograft models by
Gd-LC7-SH, a DOTA-thiol complex of gadolinium. Mice were
imaged before and at multiple time points following
treatment with RRx-001, a novel anticancer agent that
perturbs tumor redox status. Gd-LC7-SH spontaneously
binds to macromolecular thiol targets following i.v.
administration, producing prolonged shortening of tumor
T1 in untreated animals. Following treatment with
RRx-001 the washout of Gd-LC7-SH from tumors was
markedly faster, consistent with the proposed
glutathione-depleting mechanism of action of the drug.
Use of Gd-LC7-SH-enhanced MRI as a pharmacodynamic
marker of RRx-001 action is discussed.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
